Karuna Therapeutics, Inc. (NASDAQ:KRTX) Receives Average Recommendation of Hold from Analysts

Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been given an average rating of “Hold” by the sixteen analysts that are covering the stock, MarketBeat.com reports. Ten investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price target among brokers […]

Related Keywords

,Stephenk Brannan ,Cantor Fitzgerald ,Quadrant Capital Group ,Securities Exchange Commission ,Lindbrook Capital ,Nasdaq ,Russell Investments Group Ltd ,Financial Services Group Inc ,Karuna Therapeutics Inc ,Karuna Therapeutics ,Get Free Report ,Exchange Commission ,Capital Group ,Investments Group ,Services Group ,Get Free ,Karuna Therapeutics Daily ,Nasdaq Krtx ,Krtx ,Medical ,Ratings ,Consensus ,